Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Melanoma Research|April 23, 2025
Open-label nonrandomized phase IB study to characterize the safety and recommended dose of tinostamustine in combination with nivolumab in patients with advanced melanoma (ENIgMA)Markus Joerger, Stefan Diem, Nina Wyss, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2021
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patientsMette-Triin Purde, Rebekka Niederer, Nikolaus B Wagner, et al.
Journal of the American Academy of Dermatology|August 27, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitorsOmar Hasan Ali, David Bomze, Sandra S Ring, et al.
Plos Biology|April 10, 2009
Impaired antibody response causes persistence of prototypic T cell-contained virusAndreas Bergthaler, Lukas Flatz, Admar Verschoor, et al.
Npj Imaging|January 6, 2026
Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapyCécile Philippe, Jonathan Cotton, Gregory D Bowden, et al.
Immunity|August 5, 2020
Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in MelanomaMaike Effern, Nicole Glodde, Matthias Braun, et al.
Vaccine|December 3, 2014
Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiationRahul Roychoudhuri, Francois Lefebvre, Mitsuo Honda, et al.
Plos Pathogens|November 21, 2015
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted InfectionRami Sommerstein, Lukas Flatz, Melissa M Remy, et al.
Clinical Epigenetics|June 27, 2020
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanomaFriederike Hoffmann, Romina Zarbl, Dennis Niebel, et al.
Theranostics|May 22, 2023
In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRIJohannes Schwenck, Dominik Sonanini, Dominik Seyfried, et al.
Pageof 13